Loading...
The physician-editors of Journal Watch Oncology and Hematology have selected 12 articles published during the past year that we believe hold the greatest implications for clinical practice. Here are our choices for the top stories in breast cancer, gastrointestinal cancer, genitourinary cancer, head and neck cancer, palliative care, malignant hematology, and benign hematology.
One of the biggest stories of the year in breast cancer research was a recent Eastern Cooperative Oncology Group (ECOG) study that demonstrated the anticancer activity of bevacizumab, a humanized monoclonal antibody against vascular endothelial growth factor, which plays a dominant role in tumor angiogenesis (JW Oncol Hematol Jan 15 2008). Results showed t…